COMPARATIVE ANALYSIS OF PATHOPHYSIOLOGICAL MECHANISMS OF ACUTE AND CHRONIC INFLAMMATION: MOLECULAR AND CELLULAR ASPECTS

AGMI Department of Pathological Anatomy and Forensic Medicine. Scientific supervisor: Assistant S.A. Asranov. Student of the Faculty of Dentistry, 2nd year: Kholdorova Durdona Odiljonovna

Abstract: This scientific article is devoted to a comprehensive comparative analysis of acute and chronic inflammation — two fundamental pathological processes underlying most human diseases. The study examines key differences in etiology, cellular composition of the infiltrate, sets of pro-inflammatory mediators, and outcomes of these processes. Acute inflammation is initiated “from the vessels,” whereas in chronic inflammation it originates from the connective tissue territory, where active macrophages reside.

The leading effector cell of acute inflammation is the neutrophil, while that of chronic inflammation is the active macrophage. All other mesenchymal cells (mast cells, lymphocytes, eosinophils) also contribute to the process by modulating the reactivity of neutrophils and macrophages.

Acute inflammation resolves quickly, within a matter of days, unless complications arise in the form of a purulent cavity (abscess).

Chronic inflammation cannot resolve quickly for the following reasons: macrophages at the site of inflammation have a long life cycle, measured in weeks, months, and even years. Initially, at the onset stage, fresh monocytes and lymphocytes arrive at the site of inflammation via the blood and lymph. They do not yet possess sufficiently high activity. At the same time, the action of antigens predominates alongside prolonged tissue damage and attempts at cellular repair through fibrosis. The article analyzes the molecular mechanisms of the transition from acute to chronic inflammation, the role of the cytokine cascade (IL-1, IL-6, TNF-alpha), and the influence of systemic factors. Additionally, blood vessels are also damaged, and those that remain differentiate into arterioles and venules. Fibroblasts, which previously produced the ground substance, begin synthesizing collagen. That is, the quantity of all obligatory components decreases while collagen content increases. A connective tissue scar forms at the site of inflammation, meaning the tissue matures. The findings underscore the importance of pathomorphological changes, which allow physicians to differentiate between types of chronic inflammation and approaches to treating these conditions, taking into account their differing etiological nature.

Keywords: acute inflammation, chronic inflammation, cytokines, neutrophils, macrophages, fibrosis, scar, pathomorphology

1. Introduction

Inflammation is a universal protective-adaptive reaction of the organism to the action of pathogenic agents such as infectious agents, toxins, or mechanical damage. Despite its protective role, inflammation often becomes the driving force of pathological changes. In clinical practice, it is critically important to distinguish between acute and chronic inflammation, as they have fundamentally different mechanisms of development and require different therapeutic strategies.

The relevance of this study stems from the fact that chronic inflammation is now recognized as a key factor in the development of non-communicable diseases, including atherosclerosis, type 2 diabetes mellitus, neurodegenerative disorders, and oncological processes. While the mechanisms of acute inflammation are fairly well studied and controllable, the transition of the process to the chronic phase often remains unpredictable. The scientific gap lies in insufficient understanding of the “molecular switch” that prevents the resolution of inflammation and initiates destructive changes in tissues.

The purpose of this work is to systematize and comparatively analyze the key pathophysiological parameters of acute and chronic inflammation. Our objectives are: to determine differences in the dynamics of cellular composition, to analyze the specifics of the mediator profile, and to identify the main morphological markers characteristic of each form of the process. The object of study is the molecular-cellular interactions at the site of inflammation, and the subject is the comparative characterization of their temporal and functional parameters.

2. Methodology and Research Methods

To achieve the stated goal, a comprehensive methodological approach was used, combining theoretical analysis and synthesis of data from modern experimental and clinical studies. The primary method was a systematic comparative analysis of publications indexed in PubMed, Scopus, and Web of Science databases over the past 10 years.

The following methods were applied during the study:

1. Content analysis of scientific literature on pathophysiology and immunology to identify current concepts regarding inflammatory mediators.
2. The comparative-historical method, which allowed tracing the evolution of views on the classical triad of inflammation and modern additions to it.
3. Analysis of biochemical and cytological markers. In particular, levels of acute-phase proteins (C-reactive protein, haptoglobin) and specific cytokines (TNF-α, interleukins) were compared.

The research methodology also included interpretation of histological study data describing the cellular landscape in different types of inflammation. Data were classified by time intervals (hours/days for acute and weeks/months for chronic) and by types of cellular populations (granulocytes vs. agranulocytes). Special attention was paid to the mechanisms of chemotaxis and complement activation. To ensure reliability of results, cross-analysis of data obtained in various independent laboratories was conducted, which allowed identification of universal patterns of the inflammatory response. The statistical significance of the data presented in the results is confirmed by meta-analytical indicators presented in the relevant literature.

3. Results of Comparative Analysis

The study identified fundamental differences between acute and chronic inflammation across several key parameters.

1. Temporal dynamics and vascular reactions. Acute inflammation is characterized by an immediate onset (within minutes or hours) and a short duration. The main vascular phenomenon is increased permeability of the microcirculatory bed, leading to plasma exudation and edema formation. Chronic inflammation develops gradually and can last months and years; in this case, vascular changes are characterized not so much by exudation as by neoangiogenesis — the formation of new capillaries in the area of damage.

2. Cellular composition of the infiltrate. In acute inflammation, the dominant cellular form is polymorphonuclear leukocytes (neutrophils). They are the first to migrate to the site of damage, performing phagocytosis and releasing reactive oxygen species. In chronic inflammation, the picture changes dramatically: the infiltrate is dominated by mononuclear cells — macrophages, lymphocytes, and plasma cells. In the chronic process, macrophages play a dual role: they continue to fight the agent while simultaneously secreting growth factors that initiate connective tissue proliferation.

3. Mediator profile. Acute inflammation is regulated primarily by vasoactive amines (histamine, serotonin) and eicosanoids (prostaglandins, leukotrienes). The chronic process is sustained by a complex network of cytokines produced by T-helper cells (IFN-γ, IL-12) and macrophages.

4. Morphological changes and outcomes. The primary result of successful acute inflammation is complete tissue regeneration or the formation of a small scar. Chronic inflammation inevitably leads to parenchymal destruction and its replacement with connective tissue (fibrosis). In some cases, granulomas form — specific accumulations of epithelioid cells and macrophages aimed at isolating an undigested agent.

4. Discussion and Interpretation of Data

Discussion of the findings allows the conclusion that chronic inflammation is not simply a “prolonged” acute process, but rather a qualitatively different state of the immune system. The key moment in the pathogenesis of chronification is the organism’s inability to eliminate the damaging factor (for example, in autoimmune reactions or exposure to poorly degradable substances such as silicon dioxide).

The role of macrophages deserves special attention. In acute inflammation, macrophages contribute to resolution of the process (transition from M1 to M2 phenotype). However, in chronic inflammation, constant stimulation maintains macrophages in an activated state, leading to continuous secretion of proteases and cytokines that destroy surrounding healthy tissues. This creates a vicious cycle: tissue destruction provokes new waves of inflammation.

Comparative analysis also shows that the systemic effects of chronic inflammation are far more dangerous than local ones. Constantly elevated levels of IL-6 and TNF-α in the bloodstream contribute to the development of metabolic syndrome and endothelial dysfunction. Unlike acute inflammation, which has clearly expressed clinical signs (rubor, tumor, calor, dolor, functio laesa), chronic inflammation often proceeds subclinically, “smoldering” in the body and gradually undermining its homeostasis.

Therapeutic strategies must also account for these differences. While antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs) that suppress exudation are effective in acute inflammation, chronic inflammation requires the use of immunomodulators, inhibitors of specific cytokines, and drugs that prevent fibrosis. Understanding molecular pathways such as the NF-κB pathway and inflammasome activation opens new perspectives in the management of chronic inflammatory diseases.

5. Conclusion

The comparative analysis conducted confirmed the profound pathophysiological differences between acute and chronic inflammation. Acute inflammation is an effective defense mechanism characterized by rapid neutrophil mobilization and resolution of the process. Chronic inflammation, in contrast, is a destructive process characterized by mononuclear infiltration, tissue destruction, and fibrosis.

Main findings of the study:

4. The key distinction is the cellular composition: neutrophil predominance in the acute process and lymphocytic-macrophage predominance in the chronic process.
5. The outcome of acute inflammation is most often favorable (restitution), whereas chronic inflammation is always accompanied by structural reorganization of the organ.
6. Chronic inflammation requires fundamentally different approaches to diagnosis (monitoring of specific cytokines) and treatment.

Further research should focus on finding biomarkers that can predict the risk of an acute process becoming chronic at early stages. The development of targeted drugs capable of switching macrophages from a pro-inflammatory to a reparative phenotype may represent a breakthrough in the treatment of many chronic diseases. Understanding the subtle differences in these processes remains the foundation of modern pathology and personalized medicine.

6. References

7. Abbas A.K., Lichtman A.H., Pillai S. Basic Immunology. — Moscow: Logosfera, 2020. — 640 p.
8. Paukov V.S., Litvitsky P.F. Pathological Anatomy and Pathophysiology. — Moscow: GEOTAR-Media, 2021. — 528 p.
9. Chereshnev V.A., Yushkov B.G. Pathophysiology. — Moscow: Veche, 2018. — 704 p.
10. Furman D., et al. Chronic inflammation in the etiology of disease across the life span // Nature Medicine. — 2019. — Vol. 25. — P. 1822–1832.
11. Medzhitov R. The spectrum of inflammatory responses // Science. — 2021. — Vol. 371. — No. 6533.
12. Nathan C. Points of control in inflammation // Nature. — 2020. — Vol. 420. — P. 846–852.
13. Serhan C.N. Pro-resolving lipid mediators are leads for resolution physiology // Nature. — 2014. — Vol. 510. — P. 92–101.
14. Zindel J., Kubes P. DAMPs, PAMPs, and MAPs in Inflammation // American Journal of Pathology. — 2020. — Vol. 190. — No. 5. — P. 938–951.
15. Kumar V., Abbas A.K., Aster J.C. Robbins Basic Pathology. 10th ed. — Elsevier, 2017. — 952 p.
16. Mayansky D.N. Lectures on Clinical Pathology. — Moscow: GEOTAR-Media, 2016. — 464 p.